SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-006552
Filing Date
2019-08-29
Accepted
2019-08-29 16:30:11
Documents
6
Period of Report
2019-07-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT plsi-8k_071119.htm 8-K 26112
2 AUDIT COMMITTEE CHARTER ex99-1.htm EX-99.1 25887
3 NOMINATING COMMITTEE CHARTER ex99-2.htm EX-99.2 23306
4 COMPENSATION COMMITTEE CHARTER ex99-3.htm EX-99.3 21506
5 CODE OF ETHICS ex99-4.htm EX-99.4 16395
6 INSIDER TRADING POLICY ex99-5.htm EX-99.5 25520
  Complete submission text file 0001387131-19-006552.txt   140370
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

IRS No.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 8-K | Act: 34 | File No.: 000-56064 | Film No.: 191066717
SIC: 2833 Medicinal Chemicals & Botanical Products